Wang Y, Han H, Zhang F, Lv T, et al. Response to: Identifying optimal first-line treatment for advanced non-small cell lung carcinoma with high PD-L1 expression: a matter of debate. Br J Cancer 2022 Sep 5. pii: 10.1038/s41416-022-01930.
PMID: 36064586